BioCryst Pharmaceuticals Statistics

Total Valuation

BCRX has a market cap or net worth of $1.79 billion. The enterprise value is $2.29 billion.

Market Cap	1.79B
Enterprise Value	2.29B

Important Dates

The last earnings date was Monday, August 4, 2025, before market open.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

BCRX has 209.92 million shares outstanding. The number of shares has increased by 3.62% in one year.

Current Share Class	209.92M
Shares Outstanding	209.92M
Shares Change (YoY)	+3.62%
Shares Change (QoQ)	+2.15%
Owned by Insiders (%)	1.06%
Owned by Institutions (%)	85.65%
Float	207.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	18.88
PS Ratio	3.12
Forward PS	2.80
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	107.60
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.10
EV / EBITDA	39.11
EV / EBIT	41.26
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.25

Current Ratio	2.25
Quick Ratio	1.98
Debt / Equity	n/a
Debt / EBITDA	12.17
Debt / FCF	n/a
Interest Coverage	0.59

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	7.46%
Return on Invested Capital (ROIC)	10.01%
Return on Capital Employed (ROCE)	19.81%
Revenue Per Employee	$961,217
Profits Per Employee	-$61,571
Employee Count	580
Asset Turnover	1.20
Inventory Turnover	39.36

Taxes

In the past 12 months, BCRX has paid $3.52 million in taxes.

Income Tax	3.52M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.35% in the last 52 weeks. The beta is 1.10, so BCRX's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	+10.35%
50-Day Moving Average	9.23
200-Day Moving Average	8.43
Relative Strength Index (RSI)	48.39
Average Volume (20 Days)	3,664,492

Short Selling Information

The latest short interest is 25.88 million, so 12.33% of the outstanding shares have been sold short.

Short Interest	25.88M
Short Previous Month	26.78M
Short % of Shares Out	12.33%
Short % of Float	12.46%
Short Ratio (days to cover)	8.05

Income Statement

In the last 12 months, BCRX had revenue of $557.51 million and -$35.71 million in losses. Loss per share was -$0.18.

Revenue	557.51M
Gross Profit	370.64M
Operating Income	55.46M
Pretax Income	-146.50M
Net Income	-35.71M
EBITDA	58.51M
EBIT	55.46M
Loss Per Share	-$0.18

Full Income Statement

Balance Sheet

The company has $260.04 million in cash and $738.92 million in debt, giving a net cash position of -$478.88 million or -$2.28 per share.

Cash & Cash Equivalents	260.04M
Total Debt	738.92M
Net Cash	-478.88M
Net Cash Per Share	-$2.28
Equity (Book Value)	-421.59M
Book Value Per Share	-2.01
Working Capital	221.30M

Full Balance Sheet

Cash Flow

Operating Cash Flow	16.82M
Capital Expenditures	-1.06M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 66.48%, with operating and profit margins of 9.95% and -6.41%.

Gross Margin	66.48%
Operating Margin	9.95%
Pretax Margin	-5.77%
Profit Margin	-6.41%
EBITDA Margin	10.49%
EBIT Margin	9.95%
FCF Margin	n/a

Dividends & Yields

BCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.62%
Shareholder Yield	-3.62%
Earnings Yield	-1.97%
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for BCRX is $16.70, which is 95.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.70
Price Target Difference	95.78%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	16.59%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BCRX has an Altman Z-Score of -2.05 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.05
Piotroski F-Score	5